186 related articles for article (PubMed ID: 34864005)
21. Phosphoproteome analysis of the MAPK pathway reveals previously undetected feedback mechanisms.
Gnad F; Doll S; Song K; Stokes MP; Moffat J; Liu B; Arnott D; Wallin J; Friedman LS; Hatzivassiliou G; Belvin M
Proteomics; 2016 Jul; 16(14):1998-2004. PubMed ID: 27273156
[TBL] [Abstract][Full Text] [Related]
22. Resistance to MEK inhibitors: should we co-target upstream?
Poulikakos PI; Solit DB
Sci Signal; 2011 Mar; 4(166):pe16. PubMed ID: 21447797
[TBL] [Abstract][Full Text] [Related]
23. Targeted Therapy in Melanoma and Mechanisms of Resistance.
Czarnecka AM; Bartnik E; Fiedorowicz M; Rutkowski P
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605090
[TBL] [Abstract][Full Text] [Related]
24. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
25. Targeting cPLA2α inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras/MEK/ERK and Akt/β-catenin pathways.
Liao Y; Chen W; Shi W; Zha H
Cancer Chemother Pharmacol; 2021 Oct; 88(4):689-697. PubMed ID: 34255137
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
Okano J ; Rustgi AK
J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
[TBL] [Abstract][Full Text] [Related]
27. Gastrin and phorbol 12-myristate 13-acetate regulate the human histidine decarboxylase promoter through Raf-dependent activation of extracellular signal-regulated kinase-related signaling pathways in gastric cancer cells.
Höcker M; Henihan RJ; Rosewicz S; Riecken EO; Zhang Z; Koh TJ; Wang TC
J Biol Chem; 1997 Oct; 272(43):27015-24. PubMed ID: 9341140
[TBL] [Abstract][Full Text] [Related]
28. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade.
Song MS; Park YK; Lee JH; Park K
Cancer Res; 2001 Nov; 61(22):8322-30. PubMed ID: 11719466
[TBL] [Abstract][Full Text] [Related]
29. ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.
Goetz EM; Ghandi M; Treacy DJ; Wagle N; Garraway LA
Cancer Res; 2014 Dec; 74(23):7079-89. PubMed ID: 25320010
[TBL] [Abstract][Full Text] [Related]
30. ERK Mutations and Amplification Confer Resistance to ERK-Inhibitor Therapy.
Jaiswal BS; Durinck S; Stawiski EW; Yin J; Wang W; Lin E; Moffat J; Martin SE; Modrusan Z; Seshagiri S
Clin Cancer Res; 2018 Aug; 24(16):4044-4055. PubMed ID: 29760222
[No Abstract] [Full Text] [Related]
31. YY1 regulated transcription-based stratification of gastric tumors and identification of potential therapeutic candidates.
Bhaskar Rao D; Panneerpandian P; Balakrishnan K; Ganesan K
J Cell Commun Signal; 2021 Jun; 15(2):251-267. PubMed ID: 33620645
[TBL] [Abstract][Full Text] [Related]
32. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
33. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
34. Mitogen-activated protein kinase signal transduction in solid tumors.
Lei YY; Wang WJ; Mei JH; Wang CL
Asian Pac J Cancer Prev; 2014; 15(20):8539-48. PubMed ID: 25374165
[TBL] [Abstract][Full Text] [Related]
35. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer.
Seto M; Ohta M; Asaoka Y; Ikenoue T; Tada M; Miyabayashi K; Mohri D; Tanaka Y; Ijichi H; Tateishi K; Kanai F; Kawabe T; Omata M
Mol Carcinog; 2009 Aug; 48(8):703-12. PubMed ID: 19142899
[TBL] [Abstract][Full Text] [Related]
37. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
38. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
40. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
